Health Catalyst (HCAT) Q2 FY26 earnings call

Health Catalyst executed a pivotal strategic move in Q2 FY26 by divesting Vitalware for $147 million, enabling the full repayment of $160 million in credit facility debt and eliminating significant annual interest expenses. This action, part of the multi-year Project Nexus transformation, positions the company as debt-free with a strong balance sheet, allowing for focused investment in core technology opportunities and AI initiatives. While the company navigates near-term revenue headwinds from platform migrations and services work, management is prioritizing long-term value creation through d